Edding Genor Pharma Repurchases 500,000 Shares for About HK$829,000

Deep News10-20

On October 20, Edding Genor (06998.HK) repurchased 500,000 ordinary shares on the Hong Kong Stock Exchange, with a highest repurchase price of HKD1.66 per share and a lowest repurchase price of HKD1.64 per share, for a total consideration of HKD829,010.

The repurchased shares are intended to be held as treasury shares, with the number of shares to be cancelled standing at 0.

Following the repurchase, the number of issued shares (excluding treasury shares) is 1,970,559,774, the number of treasury shares is 43,566,500, and the total number of issued shares is 2,014,126,274.

The resolution granting the repurchase mandate was approved on June 26, 2026, under which the issuer may repurchase a total of 199,074,827 shares.

The number of shares already repurchased on the Stock Exchange or other stock exchanges under this mandate is 20,273,000, representing 1.02% of the number of issued shares (excluding treasury shares) as at the date the resolution was passed.

After this share repurchase, the moratorium period applicable to any further issue of new shares or re-sale or transfer of treasury shares lasts until November 19, 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment